|
humans |
54 |
|
cell line, tumor |
38 |
|
animals |
33 |
|
mice |
33 |
|
female |
30 |
|
male |
29 |
|
gene expression regulation, neoplastic |
26 |
|
middle aged |
24 |
|
metastasis |
22 |
|
nasopharyngeal carcinoma |
22 |
|
adult |
21 |
|
aged |
21 |
|
chromosome aberrations |
21 |
|
mice, nude |
21 |
|
cell cycle |
19 |
|
chemoresistance |
19 |
|
nucleic acid hybridization |
19 |
|
gene expression profiling |
17 |
|
hcc |
17 |
|
hepatocellular carcinoma |
17 |
|
prognosis |
17 |
|
reverse transcriptase polymerase chain reaction |
17 |
|
transplantation, heterologous |
17 |
|
tumor cells, cultured |
17 |
|
medical sciences |
16 |
|
cancer stem cells |
15 |
|
esophageal cancer |
14 |
|
gene amplification |
14 |
|
in situ hybridization, fluorescence |
14 |
|
neoplasm transplantation |
14 |
|
transfection |
14 |
|
tumor-initiating cells |
14 |
|
apoptosis |
13 |
|
escc |
13 |
|
gene expression |
13 |
|
genomic instability |
13 |
|
neoplasm staging |
13 |
|
blotting, western |
12 |
|
cancer stemness |
12 |
|
cd133 |
12 |
|
dna methylation |
12 |
|
drug resistance, neoplasm |
12 |
|
genes, tumor suppressor |
12 |
|
liver neoplasms - metabolism - pathology |
12 |
|
mice, scid |
12 |
|
xenograft model antitumor assays |
12 |
|
cell proliferation |
11 |
|
immunohistochemistry |
11 |
|
liver regeneration |
11 |
|
neoplasm metastasis |
11 |
|
polymorphism, single nucleotide |
11 |
|
up-regulation |
11 |
|
aged, 80 and over |
10 |
|
antigens, cd - genetics - metabolism |
10 |
|
antigens, cd - metabolism |
10 |
|
cell division |
10 |
|
china - epidemiology |
10 |
|
comparative genomic hybridization |
10 |
|
dna-binding proteins - genetics - metabolism |
10 |
|
down-regulation |
10 |
|
down-regulation - drug effects |
10 |
|
e-cadherin |
10 |
|
esophageal squamous cell carcinoma |
10 |
|
glycoproteins - metabolism |
10 |
|
loss of heterozygosity |
10 |
|
lymphatic metastasis |
10 |
|
microrna |
10 |
|
nasopharyngeal neoplasms - genetics - metabolism - pathology |
10 |
|
peptides - metabolism |
10 |
|
promoter regions, genetic |
10 |
|
spectrometry, mass, matrix-assisted laser desorption-ionization |
10 |
|
tissue array analysis |
10 |
|
adc |
9 |
|
alleles |
9 |
|
allelic imbalance |
9 |
|
arginine methylation |
9 |
|
cell cycle arrest |
9 |
|
chromosomes, human, pair 14 - genetics |
9 |
|
dce-mri |
9 |
|
dna - genetics |
9 |
|
dw-mri |
9 |
|
electrophoresis, gel, two-dimensional |
9 |
|
epigenetics |
9 |
|
gamma rays |
9 |
|
genetic predisposition to disease |
9 |
|
karyotyping |
9 |
|
microcell-mediated chromosome transfer |
9 |
|
mipol1 |
9 |
|
mrs |
9 |
|
nasopharyngeal neoplasms - genetics |
9 |
|
nuclear proteins - genetics - metabolism |
9 |
|
nucleic acid hybridization - methods |
9 |
|
oligonucleotide array sequence analysis |
9 |
|
oncology |
9 |
|
promoter hypermethylation |
9 |
|
rad51 recombinase |
9 |
|
signal transduction |
9 |
|
targeted therapy |
9 |
|
tumor markers, biological - metabolism |
9 |
|
tumor suppressor proteins - genetics - metabolism |
9 |
|
aging, premature - genetics |
8 |
|
bone marrow cells - physiology - radiation effects |
8 |
|
cancer progression |
8 |
|
carcinoma, hepatocellular - genetics - metabolism |
8 |
|
carcinoma, hepatocellular - metabolism - pathology |
8 |
|
carcinoma, hepatocellular - metabolism - pathology - secondary |
8 |
|
carcinoma, squamous cell - genetics - pathology |
8 |
|
carrier proteins - metabolism |
8 |
|
cell aging - genetics |
8 |
|
cell proliferation - drug effects |
8 |
|
chemokine cxcl1 - physiology |
8 |
|
chromosomal proteins, non-histone |
8 |
|
chromosome deletion |
8 |
|
chromosomes, human, pair 3 - genetics |
8 |
|
chromosomes, human, pair 6 - genetics |
8 |
|
disease progression |
8 |
|
dna damage - genetics |
8 |
|
dna repair - physiology |
8 |
|
epigenetic regulation |
8 |
|
etv4 |
8 |
|
fibroblasts - pathology - radiation effects |
8 |
|
gastroenterology medical sciences |
8 |
|
glycoproteins - deficiency - genetics - metabolism |
8 |
|
glycoproteins - genetics - metabolism |
8 |
|
histones - genetics - metabolism - radiation effects |
8 |
|
interleukin-8 - deficiency - genetics - physiology |
8 |
|
intracellular signaling peptides and proteins - genetics - metabolism |
8 |
|
lamin type a - genetics - metabolism |
8 |
|
liver - metabolism - pathology - physiopathology |
8 |
|
liver neoplasms - genetics - metabolism |
8 |
|
liver neoplasms - genetics - metabolism - pathology |
8 |
|
membrane proteins - genetics - metabolism |
8 |
|
metalloendopeptidases - genetics - metabolism |
8 |
|
mice, mutant strains |
8 |
|
nrp2 |
8 |
|
phosphoproteins - genetics - metabolism |
8 |
|
protein precursors - genetics - metabolism |
8 |
|
proteomics |
8 |
|
rna interference |
8 |
|
rna‐seq |
8 |
|
surgery |
8 |
|
cadherins - metabolism |
7 |
|
carcinoma, hepatocellular - drug therapy - physiopathology - secondary |
7 |
|
carcinoma, hepatocellular - metabolism |
7 |
|
carcinoma, squamous cell - genetics - pathology - secondary |
7 |
|
cell transformation, neoplastic - metabolism |
7 |
|
centromere |
7 |
|
centromere - drug effects - metabolism |
7 |
|
chromatids - genetics - metabolism |
7 |
|
chromosomal instability - genetics |
7 |
|
circulating mirna |
7 |
|
cyclin b1 - genetics - metabolism |
7 |
|
defect |
7 |
|
diagnosis and prognosis |
7 |
|
dna damage |
7 |
|
endothelial cells - drug effects |
7 |
|
epithelial cells - metabolism - physiology |
7 |
|
g 2 checkpoint |
7 |
|
g2 phase - genetics |
7 |
|
hbv infection |
7 |
|
hepatitis b, chronic - genetics - immunology - metabolism |
7 |
|
histones - metabolism |
7 |
|
hypoxia-inducible factor 1, alpha subunit - metabolism |
7 |
|
id‐1 |
7 |
|
ifnar1 |
7 |
|
immunoglobulins - deficiency - genetics - physiology |
7 |
|
inhibitor of differentiation protein 1 - antagonists & inhibitors - genetics - metabolism |
7 |
|
instability |
7 |
|
liver cancer |
7 |
|
liver neoplasms - drug therapy - physiopathology - secondary |
7 |
|
lymphatic metastasis - genetics |
7 |
|
membrane proteins - deficiency - genetics - physiology |
7 |
|
microarray analysis - methods |
7 |
|
microrna therapy |
7 |
|
mir‐338‐5p |
7 |
|
mitosis |
7 |
|
molecular sequence data |
7 |
|
nasopharyngeal neoplasms - drug therapy - genetics - metabolism |
7 |
|
neoplasm invasiveness - genetics |
7 |
|
neovascularization, pathologic - metabolism |
7 |
|
npc |
7 |
|
nuclear proteins - metabolism |
7 |
|
oligodeoxyribonucleotides, antisense - pharmacology - therapeutic use |
7 |
|
p21 |
7 |
|
p38 signaling |
7 |
|
phenotype |
7 |
|
phosphorylation |
7 |
|
proteins - antagonists & inhibitors - genetics - metabolism |
7 |
|
receptor, interferon alpha-beta - genetics |
7 |
|
snp |
7 |
|
stat5a |
7 |
|
statistics as topic |
7 |
|
structure-activity relationship |
7 |
|
survival |
7 |
|
transcription regulation |
7 |
|
transcriptional activation - physiology |
7 |
|
tumor markers, biological - genetics |
7 |
|
tumor suppressor gene |
7 |
|
twist transcription factor - metabolism |
7 |
|
vascular endothelial growth factor a - genetics - metabolism - secretion |
7 |
|
ampk |
6 |
|
antigens, differentiation - metabolism |
6 |
|
antigens, thy-1 - genetics - metabolism |
6 |
|
biomarker |
6 |
|
cancer |
6 |
|
carcinogenicity tests |
6 |
|
carcinoma - genetics - pathology |
6 |
|
carcinoma, squamous cell - genetics - metabolism - pathology |
6 |
|
cell differentiation |
6 |
|
cell line |
6 |
|
cell separation |
6 |
|
chromosome 11 |
6 |
|
chromosome mapping |
6 |
|
chromosomes, human, pair 11 |
6 |
|
chromosomes, human, pair 8 |
6 |
|
dna, neoplasm - genetics |
6 |
|
epithelial-mesenchymal transition |
6 |
|
esophageal neoplasms - genetics - metabolism - pathology |
6 |
|
flow cytometry |
6 |
|
hepatocellular carcinomas |
6 |
|
histone modifications |
6 |
|
invasiveness |
6 |
|
m2 macrophages |
6 |
|
matrix stiffness |
6 |
|
mechanoepigenetics |
6 |
|
microcell hybrid |
6 |
|
muscle development |
6 |
|
nasopharyngeal neoplasms - genetics - pathology |
6 |
|
neoplasm invasiveness |
6 |
|
neovascularization, pathologic |
6 |
|
oligo-microarray |
6 |
|
oncogene |
6 |
|
pi3k/akt |
6 |
|
polymerase chain reaction |
6 |
|
prognostic predictor |
6 |
|
silibinin |
6 |
|
stem cells - metabolism - pathology |
6 |
|
thbs2 |
6 |
|
thy1 |
6 |
|
tumor metastasis |
6 |
|
tumor microenvironment |
6 |
|
aggressiveness |
5 |
|
aldehyde dehydrogenase - metabolism |
5 |
|
antigens, cd - biosynthesis - physiology |
5 |
|
autoimmune disease |
5 |
|
base sequence |
5 |
|
bmi-1 |
5 |
|
cancer immunosuppression |
5 |
|
carcinoma, hepatocellular - genetics - metabolism - pathology |
5 |
|
carcinoma, hepatocellular - genetics - pathology |
5 |
|
carcinoma, non-small-cell lung - genetics |
5 |
|
carcinoma, squamous cell - ethnology - metabolism - pathology |
5 |
|
carcinoma, squamous cell - genetics - metabolism |
5 |
|
carrier proteins - genetics |
5 |
|
cell movement - drug effects |
5 |
|
cell survival - drug effects - physiology |
5 |
|
cgh |
5 |
|
chi-square distribution |
5 |
|
chromosomes, human, pair 20 |
5 |
|
chromosomes, human, pair 3 - ultrastructure |
5 |
|
covid-19 |
5 |
|
cyclin e |
5 |
|
dna-binding proteins - metabolism |
5 |
|
double-negative b cells |
5 |
|
drug resistance, neoplasm - physiology |
5 |
|
esophageal neoplasms - ethnology - metabolism - pathology |
5 |
|
esophageal neoplasms - genetics - metabolism |
5 |
|
fascin |
5 |
|
functional assessment |
5 |
|
genotype |
5 |
|
glycoproteins - biosynthesis - physiology |
5 |
|
grp78 |
5 |
|
hypoxia |
5 |
|
immunotherapy |
5 |
|
liver neoplasms - drug therapy - enzymology |
5 |
|
liver neoplasms - genetics - pathology |
5 |
|
lung neoplasms - genetics |
5 |
|
map kinase signaling system - drug effects - physiology |
5 |
|
methylation |
5 |
|
microfilament proteins - genetics |
5 |
|
mouth neoplasms - genetics - pathology |
5 |
|
neoplastic stem cells - drug effects - metabolism |
5 |
|
non-small cell lung cancer |
5 |
|
oncogenes |
5 |
|
oscc |
5 |
|
oxygenation |
5 |
|
oxylab po2 |
5 |
|
peptides - physiology |
5 |
|
phospholipase c delta - biosynthesis - genetics - physiology |
5 |
|
protein stability |
5 |
|
proto-oncogene proteins c-akt - biosynthesis - physiology |
5 |
|
replicative stress |
5 |
|
reproducibility of results |
5 |
|
rna, messenger - metabolism |
5 |
|
signal transduction - drug effects - physiology |
5 |
|
smoking |
5 |
|
therapeutic evaluation |
5 |
|
therapeutics |
5 |
|
tumor markers, biological - genetics - metabolism |
5 |
|
upr pathway |
5 |
|
virus integration |
5 |
|
aberrations |
4 |
|
adaptor proteins, signal transducing |
4 |
|
adenocarcinoma - pathology |
4 |
|
adolescent |
4 |
|
amino acid sequence |
4 |
|
antineoplastic combined chemotherapy protocols - pharmacology |
4 |
|
apoa-1 |
4 |
|
apoptosis - drug effects |
4 |
|
bladder cancer |
4 |
|
blotting, western - methods |
4 |
|
carcinoma, hepatocellular - enzymology - pathology |
4 |
|
carcinoma, hepatocellular - genetics |
4 |
|
carcinoma, hepatocellular - genetics - metabolism - pathology - secondary |
4 |
|
carcinoma, hepatocellular - genetics - metabolism - secondary |
4 |
|
carcinoma, hepatocellular - genetics - pathology - surgery - virology |
4 |
|
carcinoma, hepatocellular - genetics - pathology - virology |
4 |
|
carcinoma, non-small-cell lung - enzymology - genetics - pathology |
4 |
|
carcinoma, squamous cell - drug therapy - genetics - metabolism - pathology |
4 |
|
cardia |
4 |
|
cdc2 protein kinase - metabolism |
4 |
|
cdc25 phosphatases - metabolism |
4 |
|
cell adhesion |
4 |
|
cell death - drug effects |
4 |
|
cell growth processes - drug effects |
4 |
|
cell line, transformed |
4 |
|
cell movement |
4 |
|
cell transformation, neoplastic |
4 |
|
cell transformation, viral - genetics |
4 |
|
cell-free infection |
4 |
|
cells, cultured |
4 |
|
chromosome in situ hybridization |
4 |
|
chromosome instability |
4 |
|
chromosome painting - methods - statistics & numerical data |
4 |
|
chromosome segregation |
4 |
|
chromosomes, human - genetics |
4 |
|
chromosomes, human - genetics - physiology |
4 |
|
chromosomes, human, pair 12 - genetics |
4 |
|
chromosomes, human, pair 3 |
4 |
|
cisplatin - administration & dosage - pharmacology |
4 |
|
clinical effectiveness |
4 |
|
cluster analysis |
4 |
|
controlled study |
4 |
|
cytogenetic study |
4 |
|
cytogenetics |
4 |
|
cytotoxicity |
4 |
|
deletion |
4 |
|
dna helicases - metabolism |
4 |
|
dna probes |
4 |
|
dna, neoplasm - metabolism |
4 |
|
dna, viral - analysis |
4 |
|
dna-binding proteins - genetics |
4 |
|
dnmt1 |
4 |
|
drug effect |
4 |
|
drug synergism |
4 |
|
dynamics |
4 |
|
early events |
4 |
|
eif-5a2 aging |
4 |
|
eif5a |
4 |
|
epithelial cells - chemistry - metabolism - pathology |
4 |
|
epithelial cells - drug effects - pathology |
4 |
|
epithelial-mesenchymal transition - physiology |
4 |
|
epstein–barr virus |
4 |
|
esophageal carcinoma |
4 |
|
esophageal neoplasms - genetics - pathology |
4 |
|
fluorescent antibody technique |
4 |
|
g2 phase |
4 |
|
gastric cardia adenocarcinoma |
4 |
|
genes, p53 |
4 |
|
genes, tumor suppressor - physiology |
4 |
|
genome |
4 |
|
genome, human |
4 |
|
graft injury |
4 |
|
hbx |
4 |
|
head and neck neoplasms - drug therapy - genetics - metabolism - pathology |
4 |
|
helix-loop-helix motifs |
4 |
|
hep g2 cells |
4 |
|
hepatitis b virus |
4 |
|
hepatitis b virus - genetics |
4 |
|
hepatitis b virus - isolation & purification |
4 |
|
hsp70 heat-shock proteins - chemistry - genetics - metabolism |
4 |
|
human |
4 |
|
hypusination |
4 |
|
i-kappa b kinase - genetics - metabolism |
4 |
|
immortalization |
4 |
|
immune regulation |
4 |
|
immunoenzyme techniques |
4 |
|
immunohistochemistry - methods |
4 |
|
in situ hybridization |
4 |
|
in situ hybridization, fluorescence - methods - statistics & numerical data |
4 |
|
inhibitory concentration 50 |
4 |
|
intrahepatic metastasis |
4 |
|
isoenzymes - metabolism |
4 |
|
isoliquiritigenin |
4 |
|
lim domain proteins |
4 |
|
liver neoplasms - enzymology - pathology |
4 |
|
liver neoplasms - genetics |
4 |
|
liver neoplasms - genetics - metabolism - pathology - secondary |
4 |
|
liver neoplasms - genetics - metabolism - secondary |
4 |
|
liver neoplasms - genetics - pathology - secondary - virology |
4 |
|
liver neoplasms - genetics - pathology - surgery - virology |
4 |
|
liver neoplasms - metabolism |
4 |
|
liver steatosis |
4 |
|
liver transplantation |
4 |
|
lmo2 |
4 |
|
loh |
4 |
|
lung neoplasms - enzymology - genetics - pathology |
4 |
|
lung neoplasms - genetics - metabolism - secondary |
4 |
|
lymph nodes - pathology |
4 |
|
mammary tumorigenesis |
4 |
|
membrane glycoproteins - genetics - metabolism |
4 |
|
mesoderm - drug effects - pathology |
4 |
|
metalloproteins - genetics |
4 |
|
microfilament proteins - genetics - metabolism |
4 |
|
micrornas - metabolism |
4 |
|
microsatellite repeats |
4 |
|
microtubules - genetics - pathology |
4 |
|
mim-b |
4 |
|
mir-142-3p |
4 |
|
models, genetic |
4 |
|
molecular relationship |
4 |
|
multicentric occurrence |
4 |
|
mutation |
4 |
|
nasophanrygeal carcinoma |
4 |
|
nasopharyngeal epithelial cells |
4 |
|
nasopharyngeal neoplasms - drug therapy - metabolism - pathology |
4 |
|
neoplasm proteins - genetics - metabolism |
4 |
|
neoplasm proteins - metabolism |
4 |
|
neoplasm recurrence, local - diagnosis - genetics - pathology |
4 |
|
neoplastic stem cells - enzymology - pathology |
4 |
|
neoplastic stem cells - pathology |
4 |
|
nf-kappa b - antagonists & inhibitors - biosynthesis - genetics - metabolism |
4 |
|
nuclear proteins - chemistry - genetics - metabolism |
4 |
|
oncofetal molecule |
4 |
|
ovarian neoplasms - genetics |
4 |
|
ovary - pathology |
4 |
|
paclitaxel - pharmacology |
4 |
|
pentacyclic triterpenes |
4 |
|
peptide initiation factors - antagonists and inhibitors - genetics - metabolism |
4 |
|
placental site trophoblastic tumor |
4 |
|
precision medicine |
4 |
|
pregnancy |
4 |
|
prostate cancer |
4 |
|
prostatic neoplasms - genetics |
4 |
|
prostatic neoplasms - pathology |
4 |
|
protein array analysis |
4 |
|
proteome - analysis - chemistry |
4 |
|
proto-oncogene proteins |
4 |
|
rac gtp-binding proteins - metabolism |
4 |
|
real-time quantitative pc |
4 |
|
resistance |
4 |
|
rna, messenger - analysis |
4 |
|
rna, messenger - genetics |
4 |
|
rna, messenger - genetics - metabolism |
4 |
|
rna, neoplasm - analysis |
4 |
|
rna-binding proteins - antagonists and inhibitors - genetics - metabolism |
4 |
|
rna-seq |
4 |
|
roc curve |
4 |
|
ros |
4 |
|
self-renewal |
4 |
|
single-cell sequencing |
4 |
|
spectral karyotyping |
4 |
|
squamous cell carcinoma |
4 |
|
taxol |
4 |
|
telomerase - metabolism |
4 |
|
telomerase activity |
4 |
|
telomere |
4 |
|
telomere - genetics - metabolism - physiology |
4 |
|
telomere - genetics - pathology |
4 |
|
telomeres |
4 |
|
transcription factors |
4 |
|
transgenic mouse |
4 |
|
triterpenes - administration & dosage - pharmacology |
4 |
|
trophoblastic tumor, placental site - genetics - metabolism - pathology |
4 |
|
tumor growth |
4 |
|
tumor markers, biological - analysis |
4 |
|
tumor microenvionment |
4 |
|
tumor suppressor |
4 |
|
tumor suppressor protein p53 - biosynthesis - genetics |
4 |
|
tumorigenesis |
4 |
|
twist |
4 |
|
twist transcription factor |
4 |
|
urinary bladder neoplasms - genetics |
4 |
|
uroplakin ia |
4 |
|
uterine neoplasms - genetics - metabolism - pathology |
4 |
|
vascular endothelial growth factors - biosynthesis - metabolism |
4 |
|
vincristine - pharmacology |
4 |
|
wif1 demethylation |
4 |
|
wound healing |
4 |
|
2-dimensional electrophoresis |
3 |
|
20q amplification |
3 |
|
67lr |
3 |
|
actinin - analysis |
3 |
|
actn4 |
3 |
|
adenocarcinoma - epidemiology - genetics |
3 |
|
adenocarcinoma - genetics |
3 |
|
aldh |
3 |
|
annexin i |
3 |
|
anti-pd therapy |
3 |
|
antineoplastic agents - pharmacology |
3 |
|
antineoplastic agents, phytogenic - pharmacology |
3 |
|
apoptosis - physiology |
3 |
|
ataxia |
3 |
|
aurora kinase a |
3 |
|
bart microrna |
3 |
|
bile duct neoplasms - genetics - pathology |
3 |
|
bile ducts, intrahepatic - pathology |
3 |
|
biological marker |
3 |
|
biology |
3 |
|
breast and colon cancer |
3 |
|
breast cancer |
3 |
|
cancer growth |
3 |
|
cancer inhibition |
3 |
|
cancer staging |
3 |
|
cancer stem cell |
3 |
|
cancer survival |
3 |
|
carcinogenesis |
3 |
|
carcinoma, hepatocellular - blood supply - metabolism - pathology - therapy |
3 |
|
carcinoma, squamous cell - chemistry - pathology |
3 |
|
carcinoma, squamous cell - epidemiology - genetics |
3 |
|
carcinoma, squamous cell - epidemiology - genetics - pathology |
3 |
|
carcinoma, squamous cell - genetics |
3 |
|
carcinoma, squamous cell - genetics - mortality - pathology |
3 |
|
case-control studies |
3 |
|
cd68 |
3 |
|
cell cycle - physiology |
3 |
|
cell cycle proteins - genetics |
3 |
|
cell migration |
3 |
|
cerebellum development |
3 |
|
chemotherapy drug resistance |
3 |
|
cholangiocarcinoma |
3 |
|
cholangiocarcinoma - genetics - pathology |
3 |
|
chromosome 8p |
3 |
|
chromosome aberration |
3 |
|
chromosome banding |
3 |
|
chromosomes, human, pair 1 |
3 |
|
chromosomes, human, pair 10 |
3 |
|
chromosomes, human, pair 17 |
3 |
|
chromosomes, human, pair 20 - genetics |
3 |
|
chromosomes, human, pair 4 |
3 |
|
chromosomes, human, pair 6 |
3 |
|
clinicopathologic correlation |
3 |
|
cne2 |
3 |
|
cold tumor |
3 |
|
d42pd1 |
3 |
|
deletion of 3p |
3 |
|
dioscin |
3 |
|
diosgenin - analogs and derivatives - pharmacology |
3 |
|
dna helicases - genetics - physiology |
3 |
|
dna primers |
3 |
|
dna-binding proteins - genetics - physiology |
3 |
|
drug resistant gene |
3 |
|
drugs, chinese herbal - pharmacology |
3 |
|
early detection |
3 |
|
ebv |
3 |
|
epithelial cells - enzymology |
3 |
|
epstein-barr virus |
3 |
|
epstein-barr virus infections - blood - genetics - virology |
3 |
|
esophageal neoplasms - chemistry - pathology |
3 |
|
esophageal neoplasms - epidemiology - genetics |
3 |
|
esophageal neoplasms - epidemiology - genetics - pathology |
3 |
|
esophageal neoplasms - genetics |
3 |
|
esophageal neoplasms - genetics - mortality - pathology |
3 |
|
esophageal neoplasms - physiopathology - secretion |
3 |
|
fabaceae - chemistry |
3 |
|
fibroblasts - physiology - secretion |
3 |
|
fih1 |
3 |
|
fluorescence in situ hybridization |
3 |
|
gastric cancer |
3 |
|
gene deletion |
3 |
|
gene dosage - genetics |
3 |
|
gene expression regulation, enzymologic |
3 |
|
gene silencing |
3 |
|
genetics |
3 |
|
glycogen synthase kinase 3 - physiology |
3 |
|
head and neck cancer |
3 |
|
herpesvirus 4, human - genetics - isolation & purification |
3 |
|
histone-lysine n-methyltransferase - biosynthesis - genetics - metabolism |
3 |
|
hiv-1 |
3 |
|
hkgz-cc |
3 |
|
hose |
3 |
|
il-13 |
3 |
|
in situ hybridization, fluorescence - methods |
3 |
|
incidence |
3 |
|
ipscs |
3 |
|
laser-enhanced immunotherapy |
3 |
|
ldh-a |
3 |
|
liver cancer stem cells |
3 |
|
liver neoplasms - blood supply - metabolism - pathology - therapy |
3 |
|
liver neoplasms, experimental - chemically induced - genetics - pathology |
3 |
|
liver regeneration - physiology |
3 |
|
macrophage |
3 |
|
mcm2 |
3 |
|
melanoma |
3 |
|
metastatic |
3 |
|
mice, inbred balb c |
3 |
|
microfilament proteins - analysis |
3 |
|
micrornas |
3 |
|
micrornas - blood - genetics |
3 |
|
micrornas - chemistry - metabolism |
3 |
|
mir-31 |
3 |
|
mirna |
3 |
|
mitochondrion |
3 |
|
models, biological |
3 |
|
molecular biological classification |
3 |
|
monoclonal antibody |
3 |
|
nasopharyngeal neoplasms |
3 |
|
nasopharyngeal neoplasms - blood - genetics - virology |
3 |
|
nedd9 |
3 |
|
neoplasm invasiveness - physiopathology |
3 |
|
neoplasm metastasis - genetics |
3 |
|
neoplasm staging - methods |
3 |
|
neoplasms - drug therapy - metabolism - pathology |
3 |
|
neoplasms, experimental - genetics - metabolism - pathology |
3 |
|
neoplastic stem cells - drug effects - metabolism - pathology |
3 |
|
neoplastic stem cells - metabolism - pathology |
3 |
|
neovascularization, pathologic - pathology |
3 |
|
nerve-cancer crosstalk |
3 |
|
nf-κb |
3 |
|
nm23 nucleoside diphosphate kinases - biosynthesis - genetics - metabolism |
3 |
|
oncogene proteins - genetics |
3 |
|
ovarian |
3 |
|
ovarian cancer |
3 |
|
ovary - cytology - enzymology |
3 |
|
overall survival |
3 |
|
oxidative stress |
3 |
|
p300-cbp transcription factors - genetics - metabolism - physiology |
3 |
|
pcaf |
3 |
|
pd1 |
3 |
|
pdss2 |
3 |
|
peroxiredoxins |
3 |
|
peroxiredoxins - genetics - metabolism |
3 |
|
phytotherapy |
3 |
|
prognostic signature |
3 |
|
promoter regions, genetic - genetics |
3 |
|
protein kinases - genetics |
3 |
|
protein-serine-threonine kinases |
3 |
|
purkinje cell |
3 |
|
rac1 |
3 |
|
reactive oxygen species |
3 |
|
real-time polymerase chain reaction |
3 |
|
receptor, igf type 1 - metabolism |
3 |
|
receptors, laminin - analysis |
3 |
|
responsive drug release |
3 |
|
rhoa |
3 |
|
rna, viral - blood - genetics |
3 |
|
screening |
3 |
|
sox9; sox10 |
3 |
|
spatholobus suberectus |
3 |
|
stem cells - cytology - metabolism |
3 |
|
stomach neoplasms - epidemiology - genetics |
3 |
|
transcription factors - genetics - metabolism |
3 |
|
transcriptomics |
3 |
|
tumor |
3 |
|
tumor invasion |
3 |
|
tumor markers, biological - chemistry - metabolism |
3 |
|
tumor progression |
3 |
|
tyrosine transaminase - genetics |
3 |
|
ubiquinone deficiency |
3 |
|
wnt signaling pathway - physiology |
3 |
|
wnt2 protein - physiology - secretion |
3 |
|
xenopus proteins - genetics |
3 |
|
3p21 |
2 |
|
3p22 |
2 |
|
adar2 |
2 |
|
adenoviridae - genetics |
2 |
|
akr7a3 |
2 |
|
alk |
2 |
|
amplification |
2 |
|
angiogenesis |
2 |
|
antigens, cd - immunology |
2 |
|
antineoplastic combined chemotherapy protocols - therapeutic use |
2 |
|
autophagy |
2 |
|
bmp antagonist |
2 |
|
c-myc amplification |
2 |
|
cacna2d3 |
2 |
|
cadherins - biosynthesis |
2 |
|
cadherins - genetics |
2 |
|
cafs |
2 |
|
cancer metabolism |
2 |
|
cancer vaccines - immunology - therapeutic use |
2 |
|
carcinoma - enzymology - genetics - pathology |
2 |
|
carcinoma, hepatocellular - blood supply - diagnosis - genetics - pathology |
2 |
|
carcinoma, hepatocellular - diagnosis - pathology |
2 |
|
carcinoma, hepatocellular - drug therapy - metabolism |
2 |
|
carcinoma, hepatocellular - enzymology - genetics - pathology |
2 |
|
carcinoma, hepatocellular - etiology - pathology |
2 |
|
carcinoma, hepatocellular - genetics - metabolism - mortality - pathology - therapy |
2 |
|
carcinoma, hepatocellular - immunology - therapy |
2 |
|
carcinoma, hepatocellular - pathology - secondary |
2 |
|
carcinoma, hepatocellular - physiopathology |
2 |
|
carcinoma, non-small-cell lung - genetics - pathology |
2 |
|
carcinoma, squamous cell - genetics - pathology - physiopathology |
2 |
|
carrier proteins - genetics - physiology |
2 |
|
cell cycle-related kinase |
2 |
|
cell transformation, neoplastic - genetics - metabolism - pathology |
2 |
|
cenpf |
2 |
|
cervical canceri |
2 |
|
chd1l |
2 |
|
chemicals and cas registry numbers |
2 |
|
child |
2 |
|
child, preschool |
2 |
|
china |
2 |
|
chromosome 12p12.1 |
2 |
|
chromosome aberrations - genetics |
2 |
|
chromosome disorders |
2 |
|
chromosomes, artificial, yeast - genetics |
2 |
|
chromosomes, human |
2 |
|
chromosomes, human, pair 11 - genetics |
2 |
|
chromosomes, human, pair 19 |
2 |
|
chronic disease |
2 |
|
cldn3 |
2 |
|
colorectal neoplasms - metabolism - pathology |
2 |
|
cricetinae |
2 |
|
csc |
2 |
|
culture media, conditioned - pharmacology |
2 |
|
cyclin d1 |
2 |
|
cyclin-dependent kinase 4 - genetics |
2 |
|
cystectomy - methods |
2 |
|
cytogenetic analysis |
2 |
|
cytoskeleton - metabolism |
2 |
|
dendritic cells |
2 |
|
dendritic cells - immunology |
2 |
|
dna helicases - genetics - metabolism - physiology |
2 |
|
dna helicases - physiology |
2 |
|
dna-binding proteins - genetics - metabolism - physiology |
2 |
|
dna-binding proteins - physiology |
2 |
|
doxorubicin - pharmacology |
2 |
|
embryonic stem cell |
2 |
|
emt |
2 |
|
epigenesis, genetic |
2 |
|
epithelial cells - pathology |
2 |
|
esophageal neoplasms - enzymology - genetics - pathology |
2 |
|
esophageal neoplasms - genetics - pathology - physiopathology |
2 |
|
ezh2 |
2 |
|
familial escc |
2 |
|
fibroblasts - drug effects - enzymology - pathology |
2 |
|
fish |
2 |
|
fluorouracil - pharmacology - therapeutic use |
2 |
|
foxo1 |
2 |
|
g2/m transition |
2 |
|
gastric cancer progression |
2 |
|
gastroenterology |
2 |
|
gca |
2 |
|
gene regulation |
2 |
|
gene therapy - methods |
2 |
|
genes, bcl-1 - genetics |
2 |
|
genetic alterations |
2 |
|
genetic vectors |
2 |
|
gf-1r |
2 |
|
glycoproteins - genetics |
2 |
|
glycoproteins - immunology |
2 |
|
gtpase-activating proteins |
2 |
|
guanine nucleotide dissociation inhibitors |
2 |
|
guanosine triphosphate |
2 |
|
hbsag |
2 |
|
hdac |
2 |
|
hepatitis b surface antigen |
2 |
|
hepatitis, chronic - genetics |
2 |
|
hepatocellular carcinoma (hcc) |
2 |
|
hepatocyte differentiation |
2 |
|
histone deacetylase 1 - genetics - metabolism |
2 |
|
histone deacetylase 2 - genetics - metabolism |
2 |
|
histone deacetylases - biosynthesis |
2 |
|
histones - genetics - metabolism |
2 |
|
hydrophobic ion-pairing interaction |
2 |
|
ifn-γ |
2 |
|
immune |
2 |
|
immunotherapy - methods |
2 |
|
interferon-gamma - metabolism |
2 |
|
interleukin-12 - metabolism |
2 |
|
interleukin-17 - pharmacology |
2 |
|
interleukin-7 - metabolism |
2 |
|
interphase - genetics |
2 |
|
invasion |
2 |
|
jnk inhibition |
2 |
|
ki-67 antigen - biosynthesis |
2 |
|
lcm |
2 |
|
liver development |
2 |
|
liver neoplasms - blood supply - diagnosis - genetics - pathology |
2 |
|
liver neoplasms - diagnosis - pathology |
2 |
|
liver neoplasms - drug therapy - metabolism |
2 |
|
liver neoplasms - enzymology - genetics - pathology |
2 |
|
liver neoplasms - etiology - pathology |
2 |
|
liver neoplasms - genetics - metabolism - mortality - pathology - therapy |
2 |
|
liver neoplasms - pathology |
2 |
|
liver neoplasms - physiopathology |
2 |
|
lymph node metastasis |
2 |
|
lymphatic metastasis - physiopathology |
2 |
|
m2 macrophage |
2 |
|
matrix metalloproteinase 2 - biosynthesis - genetics |
2 |
|
matrix metalloproteinase 7 - metabolism |
2 |
|
matrix metalloproteinase 9 - biosynthesis - genetics |
2 |
|
metastasis suppressor |
2 |
|
metastatic lymph nodes |
2 |
|
microarray analysis |
2 |
|
micrornas - genetics - metabolism |
2 |
|
mmp10 |
2 |
|
multiprotein complexes - metabolism |
2 |
|
mutations |
2 |
|
neoplasm proteins - genetics - metabolism - physiology |
2 |
|
neoplastic stem cells - immunology |
2 |
|
neoplastic stem cells - metabolism |
2 |
|
non-small-cell lung carcinoma |
2 |
|
nuclear proteins - biosynthesis |
2 |
|
oncofetal properties |
2 |
|
oncogenic driver |
2 |
|
overexpression |
2 |
|
oxygen |
2 |
|
parp inhibitors |
2 |
|
peptide initiation factors - antagonists and inhibitors - genetics - physiology |
2 |
|
peptide initiation factors - metabolism |
2 |
|
peptide initiation factors - metabolism - physiology |
2 |
|
peptides - immunology |
2 |
|
peritoneal neoplasms - genetics - secondary |
2 |
|
phospholipase c delta - genetics - metabolism |
2 |
|
phospholipasec delta 1 |
2 |
|
pluripotent transcriptome |
2 |
|
podoplanin |
2 |
|
predictive value of tests |
2 |
|
prognosis factor |
2 |
|
prognostic factor |
2 |
|
proportional hazards models |
2 |
|
protein binding |
2 |
|
proteins - genetics - metabolism |
2 |
|
proto-oncogene proteins c-myc - biosynthesis - genetics |
2 |
|
radiotherapy |
2 |
|
rats |
2 |
|
rats, sprague-dawley |
2 |
|
receptor, fibroblast growth factor, type 2 - metabolism |
2 |
|
receptors, g-protein-coupled - genetics - metabolism - physiology |
2 |
|
recurrence |
2 |
|
repressor proteins - metabolism |
2 |
|
retrospective studies |
2 |
|
rna |
2 |
|
rna editing |
2 |
|
rna, small interfering - genetics |
2 |
|
rna-binding proteins - genetics |
2 |
|
rna-binding proteins - metabolism - physiology |
2 |
|
signal transduction - genetics |
2 |
|
single-cell transcriptomics |
2 |
|
slc22a3 |
2 |
|
smal-pcr dna fingerprinting |
2 |
|
snail |
2 |
|
sorafenib resistance |
2 |
|
sostdc1 |
2 |
|
sox5 |
2 |
|
stomach neoplasms - genetics - pathology |
2 |
|
surface marker |
2 |
|
survival analysis |
2 |
|
systemic tumor immune environment (stie) |
2 |
|
t-lymphocytes, cytotoxic - immunology |
2 |
|
tandem mass spectrometry |
2 |
|
targeted metabolomics |
2 |
|
tissue microarray |
2 |
|
trans-activators - genetics |
2 |
|
transcription factors - metabolism |
2 |
|
transcription, genetic |
2 |
|
treatment outcome |
2 |
|
trop-2 |
2 |
|
tumor immune microenvironment (time) |
2 |
|
tumor markers, biological |
2 |
|
tumor markers, biological - biosynthesis |
2 |
|
tumor suppressorgene |
2 |
|
twist transcription factor - biosynthesis |
2 |
|
uc |
2 |
|
up-regulation - genetics - physiology |
2 |
|
urinary bladder neoplasms - genetics - metabolism - pathology - surgery |
2 |
|
urinary bladder neoplasms - metabolism - pathology |
2 |
|
urothelial carcinoma |
2 |
|
variation |
2 |
|
young adult |
2 |
|
19p13.3 |
1 |
|
1q21 |
1 |
|
9,10-dimethyl-1,2-benzanthracene - toxicity |
1 |
|
a-to-i rna editing |
1 |
|
abnormalities, multiple - diagnosis - genetics |
1 |
|
abnormalities, multiple - genetics |
1 |
|
abortion, spontaneous |
1 |
|
acetyltransferases - metabolism |
1 |
|
adars |
1 |
|
adenocarcinoma - genetics - metabolism - pathology |
1 |
|
adenocarcinoma - genetics - metabolism - secondary |
1 |
|
adenocarcinoma - genetics - mortality - therapy |
1 |
|
adenocarcinoma, mucinous - genetics - metabolism - pathology |
1 |
|
adenocarcinoma, mucinous - metabolism - pathology |
1 |
|
adenoma - genetics |
1 |
|
adenosine deaminase - genetics - metabolism |
1 |
|
adipokines |
1 |
|
adjuvant radiotherapy |
1 |
|
aerobic glycolysis |
1 |
|
aging - genetics |
1 |
|
aib1 |
1 |
|
akt |
1 |
|
akt/iκb/nf-κb pathway |
1 |
|
alkyl and aryl transferases - genetics |
1 |
|
alpha-fetoproteins - metabolism |
1 |
|
alternative polyadenylation |
1 |
|
alternative splicing |
1 |
|
amplicon |
1 |
|
amplicon boundary palindrome |
1 |
|
androstadienes - therapeutic use |
1 |
|
aneuploidy |
1 |
|
animal experiment |
1 |
|
animal model |
1 |
|
animal tissue |
1 |
|
antibody array |
1 |
|
antigens, neoplasm - analysis |
1 |
|
antineoplastic agents - therapeutic use |
1 |
|
antioxidant gene |
1 |
|
apoptosis regulatory proteins - genetics - metabolism |
1 |
|
aromatase inhibitors - therapeutic use |
1 |
|
array-cgh |
1 |
|
asian continental ancestry group - genetics |
1 |
|
autistic disorder |
1 |
|
autistic disorder - genetics - pathology |
1 |
|
azgp1 |
1 |
|
azin1 |
1 |
|
biopsy |
1 |
|
biopsy, needle |
1 |
|
blotting, northern |
1 |
|
blotting, southern |
1 |
|
blotting, southern - methods |
1 |
|
bone marrow cells - pathology |
1 |
|
bone neoplasms - metabolism - secondary |
1 |
|
brain - metabolism |
1 |
|
brain neoplasms - chemistry - genetics - physiopathology |
1 |
|
brain neoplasms - genetics - physiopathology - secondary |
1 |
|
brca1 |
1 |
|
brca1 protein - genetics |
1 |
|
breast - metabolism |
1 |
|
breast neoplasms - genetics |
1 |
|
breast neoplasms - genetics - metabolism |
1 |
|
breast neoplasms - genetics - metabolism - therapy |
1 |
|
c-myc |
1 |
|
calcium-calmodulin-dependent protein kinases - genetics - metabolism |
1 |
|
cancer adjuvant therapy |
1 |
|
cancer cell |
1 |
|
cancer cell reprogramming |
1 |
|
cancer hallmarks |
1 |
|
cancer therapy |
1 |
|
capillaries - physiology |
1 |
|
capsaicin |
1 |
|
carcinogens |
1 |
|
carcinogens - toxicity |
1 |
|
carcinoma |
1 |
|
carcinoma - chemistry - mortality - pathology |
1 |
|
carcinoma, hepatocellular - blood - complications - epidemiology |
1 |
|
carcinoma, hepatocellular - genetics - pathology - secondary |
1 |
|
carcinoma, hepatocellular - genetics - secondary |
1 |
|
carcinoma, hepatocellular - immunology - virology |
1 |
|
carcinoma, hepatocellular - metabolism - secondary |
1 |
|
carcinoma, hepatocellular - virology |
1 |
|
carcinoma, non-small-cell lung - genetics - mortality - therapy |
1 |
|
carcinoma, non-small-cell lung - genetics - pathology - surgery |
1 |
|
carcinoma, non-small-cell lung - metabolism - mortality - secondary |
1 |
|
carcinoma, non-small-cell lung - metabolism - pathology |
1 |
|
carcinoma, small cell - genetics |
1 |
|
carcinoma, squamous cell - diagnosis - drug therapy - metabolism - radiotherapy |
1 |
|
carcinoma, squamous cell - drug therapy - metabolism - radiotherapy - secondary - therapy |
1 |
|
carcinoma, squamous cell - genetics - metabolism - mortality |
1 |
|
carcinoma, squamous cell - genetics - mortality - therapy |
1 |
|
carcinoma, squamous cell - metabolism |
1 |
|
carcinoma, squamous cell - mortality - pathology - therapy |
1 |
|
cathepsin x |
1 |
|
ccl2 |
1 |
|
ccl2/ccr2 |
1 |
|
ccl4 |
1 |
|
cell adhesion molecules - metabolism |
1 |
|
cell death inducing dff like effector a |
1 |
|
cell division - genetics |
1 |
|
cell motility |
1 |
|
cell nucleus - genetics - radiation effects - ultrastructure |
1 |
|
cell nucleus - metabolism - pathology |
1 |
|
cell therapy |
1 |
|
cell transformation, neoplastic - genetics |
1 |
|
cell transformation, neoplastic - pathology |
1 |
|
centromere - genetics |
1 |
|
chd1l protein |
1 |
|
chemokine |
1 |
|
chemoradiotherapy |
1 |
|
chemotherapy |
1 |
|
chickens |
1 |
|
childhood schizophrenia |
1 |
|
chip-seq |
1 |
|
chromatin |
1 |
|
chromatin - ultrastructure |
1 |
|
chromosomal aberration |
1 |
|
chromosomal aberrations |
1 |
|
chromosomal instability |
1 |
|
chromosome |
1 |
|
chromosome 12q amplification |
1 |
|
chromosome 22 |
1 |
|
chromosome aberrations - diagnosis |
1 |
|
chromosome banding - methods |
1 |
|
chromosome breakage |
1 |
|
chromosome breakage - genetics |
1 |
|
chromosome mapping - methods |
1 |
|
chromosome microdissection |
1 |
|
chromosome painting |
1 |
|
chromosome painting - methods |
1 |
|
chromosome translocation |
1 |
|
chromosomes |
1 |
|
chromosomes - genetics |
1 |
|
chromosomes - genetics - radiation effects - ultrastructure |
1 |
|
chromosomes - ultrastructure |
1 |
|
chromosomes, bacterial |
1 |
|
chromosomes, human - ultrastructure |
1 |
|
chromosomes, human, pair 1 - genetics |
1 |
|
chromosomes, human, pair 1 - genetics - ultrastructure |
1 |
|
chromosomes, human, pair 10 - genetics |
1 |
|
chromosomes, human, pair 11 - genetics - ultrastructure |
1 |
|
chromosomes, human, pair 12 |
1 |
|
chromosomes, human, pair 13 |
1 |
|
chromosomes, human, pair 13 - ultrastructure |
1 |
|
chromosomes, human, pair 16 |
1 |
|
chromosomes, human, pair 16 - genetics |
1 |
|
chromosomes, human, pair 17 - genetics |
1 |
|
chromosomes, human, pair 17 - genetics - ultrastructure |
1 |
|
chromosomes, human, pair 17 - ultrastructure |
1 |
|
chromosomes, human, pair 18 |
1 |
|
chromosomes, human, pair 19 - genetics |
1 |
|
chromosomes, human, pair 2 |
1 |
|
chromosomes, human, pair 20 - ultrastructure |
1 |
|
chromosomes, human, pair 21 |
1 |
|
chromosomes, human, pair 22 |
1 |
|
chromosomes, human, pair 4 - genetics - ultrastructure |
1 |
|
chromosomes, human, pair 5 |
1 |
|
chromosomes, human, pair 5 - genetics |
1 |
|
chromosomes, human, pair 6 - ultrastructure |
1 |
|
chromosomes, human, pair 7 |
1 |
|
chromosomes, human, pair 7 - genetics |
1 |
|
chromosomes, human, pair 8 - genetics |
1 |
|
chromosomes, human, pair 9 |
1 |
|
chromosomes, human, pair 9 - genetics |
1 |
|
circlonp2 |
1 |
|
cisplatin |
1 |
|
cisplatin - pharmacology |
1 |
|
cistrome |
1 |
|
claudins |
1 |
|
clear cell renal carcinoma |
1 |
|
cleavage and polyadenylation |
1 |
|
cleavage and polyadenylation specific factor 1 |
1 |
|
clone cells - metabolism |
1 |
|
cloning, molecular |
1 |
|
cloning, molecular - methods |
1 |
|
clusterin |
1 |
|
clusterin - analysis - physiology |
1 |
|
clusterin - blood |
1 |
|
clusterin - metabolism |
1 |
|
cohort studies |
1 |
|
colon - metabolism |
1 |
|
colonic neoplasms - genetics |
1 |
|
colorectal carcinoma |
1 |
|
colorectal neoplasms - genetics |
1 |
|
colorectal neoplasms - genetics - metabolism - pathology |
1 |
|
colorectal neoplasms - genetics - pathology |
1 |
|
colorectal neoplasms - genetics - pathology - physiopathology |
1 |
|
colorectal neoplasms, hereditary nonpolyposis - genetics |
1 |
|
colorectal tumorigenesis |
1 |
|
combined modality therapy |
1 |
|
comparative genome hybridization |
1 |
|
comparative genomic hybridization (cgh) |
1 |
|
complex chromosomal translocation |
1 |
|
computer simulation |
1 |
|
contig mapping |
1 |
|
cosmids |
1 |
|
craniofacial abnormalities - genetics |
1 |
|
cscs |
1 |
|
cxcl10 |
1 |
|
cyclin d |
1 |
|
cyclin d1 - genetics - metabolism |
1 |
|
cyclin-dependent kinase 4 |
1 |
|
cyclin-dependent kinase inhibitor p16 - genetics |
1 |
|
cyclin-dependent kinases - genetics |
1 |
|
cyclins - analysis - genetics - metabolism |
1 |
|
cyclooxygenase inhibitors - therapeutic use |
1 |
|
cystadenocarcinoma, serous - genetics |
1 |
|
cystadenocarcinoma, serous - genetics - metabolism - pathology |
1 |
|
cystadenocarcinoma, serous - metabolism - pathology |
1 |
|
cystadenoma - genetics - metabolism - pathology |
1 |
|
cytogenetic analysis - methods |
1 |
|
cytokine |
1 |
|
cytoplasm/chemistry |
1 |
|
cytoskeletal proteins - genetics |
1 |
|
ddr |
1 |
|
del(1p) |
1 |
|
digeorge syndrome |
1 |
|
digeorge syndrome - genetics |
1 |
|
dimethyl fumarate |
1 |
|
disease models, animal |
1 |
|
dissection |
1 |
|
dissection - methods |
1 |
|
dmba |
1 |
|
dms |
1 |
|
dna - chemistry - genetics |
1 |
|
dna - genetics - isolation & purification |
1 |
|
dna fragmentation - genetics |
1 |
|
dna helicases - genetics |
1 |
|
dna primers - chemistry |
1 |
|
dna probes - genetics |
1 |
|
dna repair - genetics |
1 |
|
dna topoisomerases, type i |
1 |
|
dna, antisense - genetics |
1 |
|
dna, complementary - analysis |
1 |
|
dna, complementary - genetics |
1 |
|
dna, complementary - isolation & purification |
1 |
|
dna, neoplasm |
1 |
|
dna, neoplasm - analysis |
1 |
|
dna, neoplasm - analysis - genetics |
1 |
|
dna, neoplasm - analysis - genetics - isolation & purification |
1 |
|
dna, neoplasm - genetics - isolation & purification |
1 |
|
dna, satellite - genetics |
1 |
|
dna, single-stranded |
1 |
|
dna-binding proteins |
1 |
|
dna-binding proteins - biosynthesis - genetics |
1 |
|
dopamine receptor d2 |
1 |
|
double minutes |
1 |
|
drug resistance - genetics |
1 |
|
drug resistance, multiple - genetics |
1 |
|
drug resistance, neoplasm - genetics |
1 |
|
drug screening assays, antitumor |
1 |
|
dup(4q) |
1 |
|
dynamin2 |
1 |
|
egfr |
1 |
|
eif-5a2 |
1 |
|
eif-5a2 gene |
1 |
|
eif5a-2 |
1 |
|
eif5a2 |
1 |
|
electron microscopy |
1 |
|
elf-5a2 |
1 |
|
embryonic development |
1 |
|
enzyme-linked immunosorbent assay |
1 |
|
epigenome |
1 |
|
erk |
1 |
|
erk1/2 |
1 |
|
esophageal neoplasms - diagnosis - drug therapy - metabolism - radiotherapy |
1 |
|
esophageal neoplasms - drug therapy - metabolism - pathology - radiotherapy - therapy |
1 |
|
esophageal neoplasms - genetics - metabolism - mortality |
1 |
|
esophageal neoplasms - metabolism |
1 |
|
esophageal neoplasms - mortality - pathology - therapy |
1 |
|
esophageal squamous cell carcinoma (escc) |
1 |
|
esophagus cancer |
1 |
|
estradiol - metabolism - pharmacology |
1 |
|
eukaryotic initiation factor 5a2 |
1 |
|
eukaryotic translation initiation factor 5a2 |
1 |
|
european continental ancestry group - genetics |
1 |
|
evi-1 |
1 |
|
exosome |
1 |
|
extracellular matrix |
1 |
|
eye abnormalities - genetics |
1 |
|
fam3c |
1 |
|
fertilization in vitro |
1 |
|
fetal diseases - genetics |
1 |
|
fgf3 |
1 |
|
fibroblast growth factor 3 - analysis - genetics - metabolism |
1 |
|
fibrosarcoma - genetics |
1 |
|
fluorescence in-situ hybridization |
1 |
|
follow-up studies |
1 |
|
fungal proteins - genetics |
1 |
|
fushi tarazu transcription factors |
1 |
|
fusion proteins, bcr-abl - genetics |
1 |
|
fzd7 |
1 |
|
gastric carcinoma |
1 |
|
gene amplification - genetics |
1 |
|
gene dosage |
1 |
|
gene expression - genetics |
1 |
|
gene expression regulation |
1 |
|
gene library |
1 |
|
gene rearrangement |
1 |
|
gene rearrangement - genetics |
1 |
|
gene targeting |
1 |
|
genes |
1 |
|
genes, myc - genetics |
1 |
|
genetic linkage |
1 |
|
genetic markers |
1 |
|
genetic regulation |
1 |
|
genetic techniques |
1 |
|
genetic vectors - genetics |
1 |
|
genomic library |
1 |
|
glioblastoma |
1 |
|
glioblastoma - chemistry - genetics - physiopathology |
1 |
|
glioblastoma - genetics - physiopathology - secondary |
1 |
|
glioblastoma multiform |
1 |
|
globins - genetics |
1 |
|
glyceraldehyde-3-phosphate dehydrogenases - metabolism |
1 |
|
glycogen |
1 |
|
glycolysis |
1 |
|
glycoproteins - biosynthesis |
1 |
|
grainyhead like transcription factor 1 |
1 |
|
growth disorders - genetics |
1 |
|
gynecologic |
1 |
|
gys1 |
1 |
|
h3k27me3 |
1 |
|
hbv s gene |
1 |
|
hcc differentiation |
1 |
|
hcc progression |
1 |
|
hepatic feature |
1 |
|
hepatitis b - complications - virology |
1 |
|
hepatitis b surface antigens - analysis |
1 |
|
hepatitis b, chronic - blood - complications - epidemiology |
1 |
|
hepatitis b, chronic - complications |
1 |
|
heterogeneity |
1 |
|
histiocytoma, benign fibrous - genetics - pathology - surgery |
1 |
|
histone acetyltransferases |
1 |
|
histone acetyltransferases - analysis |
1 |
|
histone acetyltransferases - analysis - genetics |
1 |
|
histone acetyltransferases - metabolism |
1 |
|
hmga1 |
1 |
|
hn1l |
1 |
|
homeodomain proteins |
1 |
|
horses - genetics |
1 |
|
hoxa5 |
1 |
|
hsr |
1 |
|
hybrid cells |
1 |
|
hybrid cells - ultrastructure |
1 |
|
igf-1 |
1 |
|
image processing, computer-assisted |
1 |
|
imipridone |
1 |
|
immunoglobulins - metabolism |
1 |
|
in situ nick-end labeling |
1 |
|
in vitro fertilization |
1 |
|
in vivo passage |
1 |
|
infant |
1 |
|
infant, newborn |
1 |
|
infertility, female |
1 |
|
inhibitor of apoptosis proteins |
1 |
|
inosine |
1 |
|
integration |
1 |
|
intelligence tests |
1 |
|
interphase |
1 |
|
interphase - physiology |
1 |
|
interphase fsh |
1 |
|
intracellular signaling peptides and proteins |
1 |
|
ish |
1 |
|
junction sequence |
1 |
|
kaplan-meier estimate |
1 |
|
karyotyping - methods |
1 |
|
kb cell |
1 |
|
kb cells |
1 |
|
ki-67 antigen - analysis |
1 |
|
kidney neoplasms - genetics - metabolism - pathology |
1 |
|
kidney neoplasms - metabolism - secondary |
1 |
|
kinesin family member c1 |
1 |
|
lectins |
1 |
|
lectins - biosynthesis |
1 |
|
leukemia, myelogenous, chronic, bcr-abl positive - genetics |
1 |
|
ligands |
1 |
|
linc01554 |
1 |
|
liver - virology |
1 |
|
liver cirrhosis - blood - epidemiology - virology |
1 |
|
liver neoplasms - blood - complications - epidemiology |
1 |
|
liver neoplasms - immunology - virology |
1 |
|
liver neoplasms - virology |
1 |
|
liver neoplasms, experimental - metabolism - pathology |
1 |
|
liver neoplasms, experimental - virology |
1 |
|
long non-coding rna (lncrna) |
1 |
|
lung cancer |
1 |
|
lung neoplasms - genetics - mortality - therapy |
1 |
|
lung neoplasms - genetics - pathology |
1 |
|
lung neoplasms - genetics - pathology - surgery |
1 |
|
lung neoplasms - metabolism - mortality - pathology |
1 |
|
lung neoplasms - metabolism - pathology |
1 |
|
lymph nodes - metabolism - pathology |
1 |
|
lymphatic metastasis - pathology |
1 |
|
lymphocytes |
1 |
|
lymphoma, b-cell - genetics |
1 |
|
m-fish |
1 |
|
mafa-as1 |
1 |
|
mammary neoplasms, experimental - chemically induced - drug therapy - pathology |
1 |
|
mapk |
1 |
|
mapk pathway |
1 |
|
maternal age |
1 |
|
matrix metalloproteinase 2 |
1 |
|
melanoma - genetics |
1 |
|
melanoma - genetics - pathology |
1 |
|
melanoma - genetics - ultrastructure |
1 |
|
met |
1 |
|
metabolic reprogramming |
1 |
|
metabolism |
1 |
|
metabolomics |
1 |
|
metaphase |
1 |
|
metastagasis |
1 |
|
metastasismicro |
1 |
|
mice, knockout |
1 |
|
microarray |
1 |
|
microdissection |
1 |
|
microdissection - methods |
1 |
|
micromanipulation |
1 |
|
microrna-146 |
1 |
|
microrna-29b |
1 |
|
micrornas - biosynthesis - genetics |
1 |
|
microsatellite repeats - genetics |
1 |
|
microscopy, electron |
1 |
|
microtubule-associated proteins - biosynthesis |
1 |
|
migration |
1 |
|
mir-130b-3p |
1 |
|
mir-9 |
1 |
|
mitosis - genetics |
1 |
|
mmp1 |
1 |
|
mmp2/9 |
1 |
|
models, anatomic |
1 |
|
molecular chaperones - genetics |
1 |
|
molecular chaperones - genetics - metabolism |
1 |
|
molecular probe techniques |
1 |
|
molecular probes |
1 |
|
multicolor fluorescence in situ hybridization |
1 |
|
multidrug resistance |
1 |
|
multigene family |
1 |
|
multigene family - genetics |
1 |
|
multiple congenital anomalies |
1 |
|
multistage |
1 |
|
multivariate analysis |
1 |
|
muts homolog 2 protein |
1 |
|
nasopharyngeal neoplasm |
1 |
|
nasopharyngeal neoplasms - drug therapy - genetics - pathology |
1 |
|
nasopharyngeal neoplasms - pathology |
1 |
|
neoadjuvant therapy |
1 |
|
neoplasm invasiveness - genetics - pathology |
1 |
|
neoplasm proteins - biosynthesis |
1 |
|
neoplasm proteins - biosynthesis - genetics |
1 |
|
neoplasm recurrence, local - epidemiology - genetics |
1 |
|
neoplasms - chemically induced - epidemiology - pathology |
1 |
|
neoplasms - genetics |
1 |
|
neoplasms, glandular and epithelial - etiology - mortality - pathology |
1 |
|
neoplasms, hormone-dependent - genetics - metabolism |
1 |
|
neoplastic stem cells - drug effects - pathology |
1 |
|
neovascularization, pathologic - genetics - metabolism - pathology |
1 |
|
nf-kappa b - metabolism |
1 |
|
nih 3t3 cells |
1 |
|
nitriles - therapeutic use |
1 |
|
non-small cell lung carcinoma |
1 |
|
nonsmall cell lung carcinoma |
1 |
|
northern china |
1 |
|
nsclc |
1 |
|
ntkl |
1 |
|
nuclear factor-κb |
1 |
|
nuclear proteins |
1 |
|
nuclear proteins - antagonists & inhibitors - biosynthesis - genetics |
1 |
|
nuclear proteins - biosynthesis - genetics |
1 |
|
nuclear receptor coactivator 1 |
1 |
|
nuclear receptor coactivator 2 |
1 |
|
nuclear receptor coactivator 3 |
1 |
|
nuclear receptor coactivator 3 - genetics |
1 |
|
nuclear receptor coactivators |
1 |
|
nucleic acid amplification techniques |
1 |
|
oesophageal squamous cell carcinoma |
1 |
|
oestrogen |
1 |
|
oligonucleotide array sequence analysis - methods |
1 |
|
oncogene proteins - metabolism |
1 |
|
oncogenes - genetics |
1 |
|
oncogenic dedifferentiation |
1 |
|
oocytes - metabolism |
1 |
|
open reading frames |
1 |
|
organ specificity |
1 |
|
osteosarcoma - genetics |
1 |
|
outcomes |
1 |
|
ovarian carcinoma |
1 |
|
ovarian neoplasms - etiology - mortality - pathology |
1 |
|
ovarian neoplasms - genetics - metabolism |
1 |
|
ovarian neoplasms - genetics - metabolism - pathology |
1 |
|
ovarian neoplasms - genetics - pathology |
1 |
|
ovarian neoplasms - metabolism - pathology |
1 |
|
ovarian tumor |
1 |
|
ovary - metabolism |
1 |
|
oxidative dna damage |
1 |
|
p300 |
1 |
|
p53 |
1 |
|
painting probe |
1 |
|
paraffin embedding |
1 |
|
pathogenesis |
1 |
|
pedigree |
1 |
|
peptide initiation factors - antagonists & inhibitors - biosynthesis - genetics |
1 |
|
peptide initiation factors - biosynthesis - genetics |
1 |
|
peptide initiation factors - genetics |
1 |
|
peptide initiation factors - genetics - metabolism |
1 |
|
peutz-jeghers syndrome - genetics |
1 |
|
philadelphia chromosome |
1 |
|
physical chromosome mapping - methods |
1 |
|
physical mapping |
1 |
|
pkm2 |
1 |
|
ploidies |
1 |
|
polycythemia vera - genetics - pathology |
1 |
|
polymerase chain reaction - methods |
1 |
|
polymorphism, genetic |
1 |
|
polymorphism, single-stranded conformational |
1 |
|
portal vein |
1 |
|
portal vein - pathology |
1 |
|
pregnancy trimester, first |
1 |
|
pregnancy, high-risk |
1 |
|
prenatal diagnosis |
1 |
|
prenatal diagnosis - methods |
1 |
|
prevalence |
1 |
|
probability |
1 |
|
prognostic marker |
1 |
|
prognostic significance |
1 |
|
prognostic value |
1 |
|
proliferation |
1 |
|
prostatic neoplasms - genetics - pathology - surgery |
1 |
|
protein expression |
1 |
|
protein-serine-threonine kinases - genetics |
1 |
|
protein-serine-threonine kinases - genetics - physiology |
1 |
|
proto-oncogene proteins - biosynthesis - genetics |
1 |
|
proto-oncogene proteins - genetics |
1 |
|
proto-oncogene proteins c-akt |
1 |
|
proto-oncogenes |
1 |
|
psychosis |
1 |
|
pyrazoles - therapeutic use |
1 |
|
rad51 |
1 |
|
radiation sensitivity and chromosome abnormality |
1 |
|
radiation tolerance - genetics |
1 |
|
receptor, epidermal growth factor - analysis - genetics |
1 |
|
receptor, erbb-2 - analysis - genetics |
1 |
|
receptors, cytoplasmic and nuclear |
1 |
|
receptors, cytoplasmic and nuclear - genetics - metabolism - physiology |
1 |
|
receptors, estrogen - genetics - metabolism |
1 |
|
receptors, prolactin - genetics - metabolism |
1 |
|
recombinant fusion proteins - genetics - metabolism |
1 |
|
reference values |
1 |
|
replication origin - genetics |
1 |
|
repressor proteins - biosynthesis - genetics |
1 |
|
rhcg |
1 |
|
ring chromosome 1 |
1 |
|
ring chromosomes |
1 |
|
risk assessment |
1 |
|
rna splicing |
1 |
|
rna, messenger - isolation & purification |
1 |
|
rna, neoplasm - metabolism |
1 |
|
rna-17 |
1 |
|
saccharomyces cerevisiae - genetics |
1 |
|
saccharomyces cerevisiae proteins |
1 |
|
sarcomas |
1 |
|
schizophrenia - genetics |
1 |
|
schizophrenia - genetics - pathology |
1 |
|
sd rat |
1 |
|
sei-1 |
1 |
|
sei1 |
1 |
|
sensitivity and specificity |
1 |
|
sequence |
1 |
|
sequence alignment |
1 |
|
sequence analysis, dna |
1 |
|
sequence analysis, dna - methods |
1 |
|
sequence deletion |
1 |
|
sequence homology, amino acid |
1 |
|
sertad1 |
1 |
|
skin neoplasms - genetics |
1 |
|
small molecule |
1 |
|
snrpb |
1 |
|
social isolation |
1 |
|
src-3 |
1 |
|
stem cell-like properties |
1 |
|
stemness |
1 |
|
steroidogenic factor 1 |
1 |
|
stomach neoplasms - chemistry - mortality - pathology |
1 |
|
stomach neoplasms - enzymology - genetics - pathology |
1 |
|
stomach neoplasms - genetics |
1 |
|
stomach neoplasms - metabolism - mortality - pathology |
1 |
|
sulfonamides - therapeutic use |
1 |
|
survival rate |
1 |
|
survivin |
1 |
|
swine - genetics |
1 |
|
syndrome |
1 |
|
t-cell exclusion |
1 |
|
tcf-4 |
1 |
|
telomere - genetics |
1 |
|
telomere - ultrastructure |
1 |
|
telomeric band |
1 |
|
testis - metabolism |
1 |
|
tetrasomy 9p |
1 |
|
tfam |
1 |
|
therapeutic resistance |
1 |
|
therapeutic targets |
1 |
|
tissue array analysis - methods |
1 |
|
tissue culture |
1 |
|
tissue microarray technique |
1 |
|
tp53 |
1 |
|
trans-activators - analysis |
1 |
|
trans-activators - analysis - genetics |
1 |
|
trans-activators - antagonists & inhibitors - biosynthesis - genetics |
1 |
|
trans-activators - chemistry - genetics |
1 |
|
trans-activators - genetics - metabolism |
1 |
|
trans-activators - genetics - metabolism - physiology |
1 |
|
trans-activators - metabolism |
1 |
|
transcription factor |
1 |
|
transcription factors - genetics |
1 |
|
transcription factors - genetics - metabolism - physiology |
1 |
|
transcription factors - physiology |
1 |
|
transcriptional activation |
1 |
|
transcriptional activation - genetics |
1 |
|
transcriptome |
1 |
|
transfection - genetics |
1 |
|
transforming growth factor beta1 - genetics - metabolism |
1 |
|
translocation |
1 |
|
translocation, genetic |
1 |
|
translocation, genetic - genetics |
1 |
|
triazoles - therapeutic use |
1 |
|
trisomy |
1 |
|
trisomy - genetics |
1 |
|
trpm7 |
1 |
|
tslc1 |
1 |
|
tumor marker |
1 |
|
tumor markers, biological - biosynthesis - genetics |
1 |
|
tumor of the ovary |
1 |
|
tumor recurrence |
1 |
|
tumor suppressor genes |
1 |
|
tumor suppressor protein p53 - analysis - genetics - physiology |
1 |
|
tumor suppressor protein p53 - metabolism |
1 |
|
tumor suppressor proteins - analysis - physiology |
1 |
|
tumour biomarkers |
1 |
|
two-dimensional gel electrophoresis |
1 |
|
two-hybrid system techniques |
1 |
|
type i collagen |
1 |
|
upa |
1 |
|
urinary bladder neoplasms - chemistry - mortality - pathology |
1 |
|
urothelial carcinoms of the bladder |
1 |
|
urothelium - chemistry - pathology |
1 |
|
usp14 |
1 |
|
uterine cervical neoplasms - genetics |
1 |
|
uterine serous cancer |
1 |
|
vascular neoplasms - genetics - pathology - secondary |
1 |
|
vasculature remodeling |
1 |
|
velocardiofacial syndrome |
1 |
|
vimentin |
1 |
|
vimentin - genetics - physiology |
1 |
|
vinblastine - pharmacology |
1 |
|
viral integration |
1 |
|
wnt |
1 |
|
x gene |
1 |
|
xenograft |
1 |
|
xenopus |
1 |
|
ykl-40 |
1 |
|
zinc finger |
1 |
|
zinc fingers - physiology |
1 |
|
zipk |
1 |
|
zipper-interacting protein kinase |
1 |
|
β-catenin |
1 |
